Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

This is an audio transcript of the FT News Briefing podcast episode: ‘Inside the Trump tariff debate’ Kasia Broussalian Good morning from the Financial Times. Today is Wednesd ...

An economist's harrowing escape from fire and her big ideas to rescue California from its insurance doom spiral.

Tesla’s latest earnings report reveals a rare sales decline and stock dip, as CEO Elon Musk’s escalating controversies and ...

ImmunityBio shares were up 14% to $3.52 after the company entered into a collaboration and supply agreement with BeiGene. The two companies will conduct a confirmatory randomized Phase 3 clinical ...

However, the U.S. stock market could move sharply on Jan. 29 and Jan. 30 based on commentary from the Federal Reserve, and ...

Several students across the Sacramento area will participate in a challenge that will teach them financial literacy. The ...

Nick Kalivas of Invesco suggests a growth strategy that lowers investors’ risk from the S&P 500’s Big Tech concentration.

The Federal Reserve's interest-rate decision comes today, U.S. stock futures are little changed after yesterday's market rebound, and "Magnificent Seven" members Tesla, Microsoft, and Meta Platforms ...

Goldman Sachs's “Rule of 10” aims to identify the next wave of S&P 500 stocks capable of delivering the most capital appreciation by focusing on past and future revenues. It's a stock screen, which ...